Albina Benabaye
Adolescent Medicine · Stockton, CANPI 1346239613
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novo Nordisk at 28.1% of the total. Reporting peaked in 2020 at $1,730 and has fallen 86.2% since, to $238 in 2022. Among adolescent medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$747
- Sanofi-aventis U.S. LLC$506
- Kowa Pharmaceuticals America, Inc.$475
- Lilly USA, LLC$403
- Johnson & Johnson$329
- plus $1K from 11 others
What the payments were for
- Food & beverage$5,062100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $1,425 |
| AstraZeneca | 29 | $747 |
| Sanofi-aventis U.S. LLC | 22 | $506 |
| Kowa Pharmaceuticals America, Inc. | 19 | $475 |
| Lilly USA, LLC | 20 | $403 |
| Johnson & Johnson | 21 | $329 |
| Boehringer Ingelheim | 13 | $299 |
| Pfizer | 7 | $199 |
| Bayer | 7 | $157 |
| Merck | 6 | $126 |
| Novartis | 6 | $125 |
| Amgen | 4 | $105 |
| Amarin Pharma, Inc. | 5 | $90 |
| Mannkind Corporation | 2 | $28 |
| GSK | 1 | $23 |
| Boston Scientific | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,074 in reported general payments places this provider in the 95th percentile of 202 adolescent medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 20 | $108 |
| Metformin Hcl | 21 | $90 |
Paid to pharmacies, not to this prescriber.
Other adolescent medicine in Stockton
- Leman YelOrange$89K
- Michelle RolandLos Angeles$22K
- Venu Prabakerla Mesa$15K
- Kanani TitchenSan Diego$8K
- David NguyenFountain Valley$6K
- Anahit BlikianGlendale$5K
- Lisa LawSan Francisco$5K
- Marilou CruzDowney$5K
- Mohamad KadriLos Angeles$5K
- Andrew KrasnoffEncino$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.